Creating New Businesses in 4 Priority Areas, with Healthcare as the Highest Priority
First written in FY2017. 8 of 15 entries say "Restated". Latest entry: FY2026.
56 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In particular, the company aims to contribute to failure analysis in semiconductor manufacturing processes by using electron microscopes and nondestructive testing equipment.」
New businesses and growth themes in 4 social value creation areas progressed into specific applications, including failure analysis in semiconductor manufacturing processes, PFAS, new energy, surface observation, and clinical MS. - FY2024AdvancedAnnual report
「In addition to advancing the deployment of gas chromatographs and other products in new energy development, including hydrogen, and greenhouse gas (GHG) measurement, the Company plans to expand the use of new products jointly developed with French oil major TotalEnergies and others in biofuel quality control.」
Initiatives in the four growth fields progressed into specific market and product themes, including hydrogen and GHG measurement, co-developed products for biofuels with TotalEnergies and other companies, and PFAS analysis. - FY2023ReframedAnnual report
「The company pursued the strengthening and expansion of four growth strategies: priority businesses, overseas businesses, recurring businesses and four growth fields.」
The former four priority areas have been reorganized under the new medium-term management plan into four growth areas centered on Healthcare, Green, Materials and Industry, and are being promoted together with priority businesses, overseas operations and recurring revenue. - FY2022AdvancedAnnual report
「Of the 4 growth areas, the healthcare field will pursue business expansion by focusing on infectious diseases, dementia and cancer, as well as cell businesses such as regenerative medicine. In the environment and energy and materials fields, the company will accelerate businesses involving electric mobility, batteries, new energy using hydrogen and ammonia, and renewable energy, with a focus on carbon neutrality.」
Initiatives in growth fields have expanded into specific business themes, including infectious diseases, dementia, cancer and regenerative medicine, as well as electric mobility, batteries, hydrogen and ammonia. - FY2021AdvancedAnnual report
「In the advanced healthcare field, we will develop the business primarily from the two perspectives of addressing an aging population and combating infectious diseases. In the environment and energy field, we will accelerate commercialization by creating mechanisms such as virtual exhibitions that propose solutions in electric mobility, including electric vehicles, batteries and renewable energy. In the materials field, we will consider business concepts centered on materials informatics using combined data from materials measurement and component analysis.」
Specific commercialization themes were presented for the four growth areas, including aging and infectious diseases, electric mobility and batteries, materials informatics, and social infrastructure. - FY2020AdvancedAnnual report
「Using the creation of markets, such as functional food analysis conducted with the North America Innovation Center and domestic research institutions, as an early example, the company will strengthen collaboration with external business partners and accelerate the creation of new markets. To this end, it will utilize the newly opened Healthcare R&D Center, strengthen the functions of innovation centers around the world, and establish a new framework for developing business seeds.」
In growth fields including healthcare, initiatives have taken concrete form to create markets using functional food analysis as an initial example, utilize the healthcare R&D center and strengthen the innovation center. - FY2020-Q3RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of investing in growth fields, including healthcare, has been reaffirmed. - FY2020-Q2RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of investing in growth fields, including healthcare, has been reaffirmed. - FY2020-Q1RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of investing in growth areas such as advanced healthcare remains in place. - FY2019-Q3RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of making growth fields, including healthcare, priority investment targets has continued. - FY2019-Q2RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of making growth fields, including healthcare, priority investment targets has continued. - FY2019-Q1RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of making growth fields, including healthcare, priority investment targets has continued. - FY2018-Q2RestatedAnnual report
「Investment in growth fields such as “Advanced Healthcare”」
The policy of focusing investment on growth fields such as Advanced Healthcare remains in place. - FY2018-Q1RestatedAnnual report
「Investment in growth fields such as Advanced Healthcare」
The policy of investing in growth fields, including healthcare, has been reaffirmed as a measure under the plan. - FY2017First statedAnnual report
「We have designated healthcare as our highest-priority area, together with infrastructure, materials, and the environment and energy, making four priority areas in total, and will create new businesses by leveraging our strengths, including by strengthening the integration of analytical and medical instruments.」
First presentation of the four priority areas—healthcare, infrastructure, materials, and environment and energy—with healthcare designated as the highest priority, together with the initiative to integrate analytical and medical instruments.